Tyra Biosciences (TYRA) Prepaid Assets (2020 - 2026)
Tyra Biosciences' (TYRA) quarterly Prepaid Assets came in at $11.1 million in Q1 2026, up 98.24% YoY from $5.6 million in Q1 2025, and up 18.0% on a QoQ basis from $9.4 million in Q4 2025.
Analysis
Tyra Biosciences (TYRA) Prepaid Assets (2020 - 2026) Analysis & Trends
Tyra Biosciences (TYRA) has 7 years of Prepaid Assets data on file, last reported at $11.1 million in Q1 2026.
- Quarterly Prepaid Assets rose 98.24% year-over-year to $11.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.1 million (up 98.24% YoY) and the FY2025 annual result came in at $9.4 million, up 56.87% from the prior year.
- Prepaid Assets advanced to $11.1 million in Q1 2026, from $9.4 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $11.1 million in Q1 2026 to a low of $1.5 million in Q1 2022.
- A 5-year average of $6.3 million and a median of $6.0 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 528.32% — and 2024, when it sank 42.66%.
- Tracing TYRA's Prepaid Assets over 5 years: stood at $6.1 million in 2022, then soared by 35.01% to $8.2 million in 2023, then declined by 26.58% to $6.0 million in 2024, then jumped by 56.87% to $9.4 million in 2025, then climbed by 18.0% to $11.1 million in 2026.
- The last three Prepaid Assets figures came in at $11.1 million (Q1 2026), $9.4 million (Q4 2025), and $6.3 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Tyra Biosciences | 1.94 Bn | 1.94 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.02 Mn |
| Mar 31, 2026 | 11.15 Mn |
| Dec 31, 2025 | 9.45 Mn |
| Sep 30, 2025 | 6.29 Mn |
| Jun 30, 2025 | 5.88 Mn |
| Mar 31, 2025 | 5.62 Mn |
| Dec 31, 2024 | 6.02 Mn |
| Sep 30, 2024 | 5.48 Mn |
| Jun 30, 2024 | 4.78 Mn |
| Mar 31, 2024 | 8.32 Mn |
| Dec 31, 2023 | 8.20 Mn |
| Sep 30, 2023 | 8.98 Mn |
| Jun 30, 2023 | 8.33 Mn |
| Mar 31, 2023 | 5.01 Mn |
| Dec 31, 2022 | 6.08 Mn |
| Sep 30, 2022 | 4.26 Mn |
| Jun 30, 2022 | 2.19 Mn |
| Mar 31, 2022 | 1.53 Mn |
| Dec 31, 2021 | 1.88 Mn |
| Sep 30, 2021 | 678,000.00 |